For Scientific Researchers

Funding Opportunities

Research at NIAMS

Accelerating Medicines Partnership (AMP)

NIAMS on Twitter

Community Outreach Initiative

Community Outreach Initiative image

NIH Loan Repayment Programs

Loan Repayment Program

NIAMS: National Institute of Arthritis and Musculoskeletal and Skin Diseases Home Page

Our Research Focus

Studies Seeking Patients

NIAMS Highlights


NIAMS Highlights

NIH Osteoporosis and Related Bone Diseases ~ National Resource Center

NRC Widget

Collage of people and All of Us logo.

All of Us Announces Funding Opportunity for Community Partners

The NIH has announced a new opportunity for organizations interested in helping engage volunteers in the All of Us Research Program, part of the Precision Medicine Initiative. This funding opportunity will support activities to promote enrollment and retention in the program across diverse communities.

Photo of Dr. Francis Collins.

NIH Awards Aim to Understand Molecular Changes During Physical Activity

The NIH Common Fund announces the first awards for the Molecular Transducers of Physical Activity in Humans Program, which will allow researchers to develop a comprehensive map of the molecular changes that occur in response to physical activity.

Photo of Dr. Gadina.

Tofacitinib Shows Potential for Treating Lupus

A drug that effectively treats rheumatoid arthritis and can improve symptoms in other autoimmune diseases may also control the symptoms associated with systemic lupus erythematosus (SLE or lupus) and potentially slow the diseaseís progression.

Microscope image of muscle fibers.

Sex-Differences in Achilles Tendon Properties May Explain Why Ruptures Occur More Often in Men

A new study in rats has revealed differences between males and females in the physical properties of the Achilles tendon. The results may explain why the incidence of ruptures is about five times higher in men than women.

Mucous membranes showing disease-causing antibody levels.

Engineered T Cells Alleviate Autoimmune Skin Disease in Mice

A new study has shown that engineered T cells can destroy antibody-producing cells that underlie a rare autoimmune disorder of the skin. The findings offer a new strategy for treating the disease, pemphigus vulgaris, and possibly certain other autoimmune conditions as well.

Multimedia

more multimedia

Video

Video

Audio

Audio

Alopecia Areata, Fast Facts
Time: 09:02 | Size: 8.5 MB

Images

Images